Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Nesacaine-mpf Generic Name & Formulations
Legal Class
Rx
General Description
Chloroprocaine HCl 20mg/mL, 30mg/mL; soln for inj; preservative-free.
Pharmacological Class
Local anesthetic.
See Also
How Supplied
Nesacaine: Multi-dose vial (30mL)—25; Nesacaine-MPF: Single-dose vial (20mL)—25
Manufacturer
Nesacaine-mpf Indications
Indications
Production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks.
Nesacaine-mpf Dosage and Administration
Adult
Epidural anesthesia: administer test dose first; monitor for CNS or cardiovascular toxicity. See full labeling for dosing based on procedure. Individualize. Max single recommended dose: 11mg/kg, not to exceed max total dose of 800mg. Debilitated, elderly, acutely ill (cardiac and/or liver disease): reduce dose.
Children
<3yrs: see full labeling. Individualize based on age and weight. ≥3yrs: max 11mg/kg.
Nesacaine-mpf Contraindications
Not Applicable
Nesacaine-mpf Boxed Warnings
Not Applicable
Nesacaine-mpf Warnings/Precautions
Warnings/Precautions
Not for subarachnoid administration. Lumbar and caudal epidural anesthesia: caution with existing neurological disease, spinal deformities, septicemia, severe hypertension. To be administered under the supervision of experienced clinicians. Have intubation, artificial respiration, oxygen therapy and reversal agents available. Risk of methemoglobinemia (esp. in G6PD deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants <6 months of age, concurrent exposure to oxidizing agents or metabolites); monitor. Hypotension. Heart block. Monitor cardiovascular and respiratory vital signs. Impaired cardiovascular function. Hepatic impairment. Retrobulbar block. Labor & delivery. Pregnancy (Cat.C). Nursing mothers.
Nesacaine-mpf Pharmacokinetics
See Literature
Nesacaine-mpf Interactions
Interactions
Concomitant sulfonamides: not recommended. Concurrent vasopressor and ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents. Increased risk of methemoglobinemia when concurrently exposed to nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, others.
Nesacaine-mpf Adverse Reactions
Adverse Reactions
CNS effects (eg, excitation, depression, restlessness, anxiety, dizziness, tremors), cardiovascular effects (eg, myocardium depression, decreased cardiac output, heart block, hypotension, bradycardia, ventricular arrhythmias, cardiac arrest), allergic-type reactions, neurologic effects (eg, spinal block, urinary retention, paresthesia, weakness, headache, paralysis of lower extremities).
Nesacaine-mpf Clinical Trials
See Literature
Nesacaine-mpf Note
Not Applicable
Nesacaine-mpf Patient Counseling
See Literature
